Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype
Corrado Pelaia(Magna Graecia University), Nunzio Crimi(University of Catania), Raffaele Campisi(University of Catania), Claudia Crimi(Marconi University), Girolamo Pelaia(Magna Graecia University), Santi Nolasco(University of Catania), Giuseppe Valenti(University of Palermo), Enrico Heffler(Humanitas University)
Cited by 77
Related Papers
EUFOREA consensus on biologics for CRSwNP with or without asthma
|Allergy|2019|378
Eosinophilic and Noneosinophilic Asthma
|CHEST Journal|2021|262
A European survey of noninvasive ventilation practices
|European Respiratory Journal|2010|205
Toward clinically applicable biomarkers for asthma: An <scp>EAACI</scp> position paper
|Allergy|2019|192
Determinants of tracheostomy decannulation: an international survey
|Critical Care|2008|177